AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
via HealthDayKey Takeaways
WEDNESDAY, April 29, 2026 — Attention-deficit/hyperactivity disorder, or ADHD, affects millions of children, but many go years without a diagnosis, missing the chance for early support.
Now, a new study from Duke Health, published April 27 in the journal Nature Mental Health, suggests artificial intelligence could help change that.
"We have this incredibly rich source of information sitting in electronic health records," said lead author Elliot Hill, a data scientist at Duke University School of Medicine in Durham, North Carolina. "The idea was to see whether patterns hidden in that data could help us predict which children might later be diagnosed with ADHD, well before that diagnosis usually happens."
Hill and his colleagues created an AI model that estimated a child's risk of developing ADHD — years before a typical diagnosis.
The AI model reviewed medical data from more than 140,000 children, with and without ADHD, from birth through early childhood. It learned to spot combinations of developmental, behavioral and clinical signs that often appear long before diagnosis.
The model proved highly accurate at estimating future ADHD in children age 5 and older. Results were consistent across sex, race, ethnicity and insurance status.
Researchers say the tool can flag kids for earlier evaluation, diagnosis and support. This is important because early intervention is linked to better academic, social and health outcomes.
"This is not an AI doctor," said senior author Dr. Matthew Engelhard, also from Duke University School of Medicine. "It's a tool to help clinicians focus their time and resources, so kids who need help don't fall through the cracks or wait years for answers."
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-30 02:19
Read more
- Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
- U.S. FDA Grants Full Approval of Kite’s Tecartus for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma
- More Than Four in 10 Adults Not Up to Date on Measles Vaccine
- Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds
- Study Looks at CRC Risk, Non-CRC Mortality in Seniors With Prior Adenoma
- Neonatal Abstinence Syndrome May Not Impact Academic Performance
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions